Jason Grillo Email & Phone Number

Seattle, Wa, Us

AirMiners is dedicated to removing the first 1 billion tons of CO2 from the atmosphere by the end of 2030, by empowering a community of carbon removal innovators worldwide, and accelerating early stage carbon removal startups as they cross the chasm to first customer and first investment. Our vision is a thriving future carbon removal industry ecosystem across all methods of greenhouse gas removal.

Regional carbon removal policy organization focused on carbon removal policy advocacy at the state, provincial, and local levels up and down the Pacific Coast of North America. PACCLEAN.org

Independent consulting on brand strategy, virtual event management, marketing insights and analytics. Climate and renewable energy focus.

Advisory Board member for company focused on facilitating the implementation and deployment of negative emissions technologies (NETs), helping organisations to achieve their mitigation commitments for addressing climate change.

Durham, North Carolina, Us

Seattle, Wa, Us

• Managed brand planning process for leading pharmaceutical product with over $800M in revenue.• Reformed competitive intelligence business process for pre-commercial biotech client.• Managed vendor selection for competitive intelligence tool, presenting recommendation to Chief Commercial Officer.

San Francisco, California, Us

• Distinguished record of achievement managing team at growing multi-state dental insurance carrier with 2017 revenues of $9.2B. • Received “Step-Up” award twice recognizing achievements.• Led team of five market competitive intelligence professionals to discover market opportunities for dental insurance offerings.• Oversaw market research projects focused on enrollees, benefit administrators, brokers, and providers. Budget over $1M.

Campbell, California, Us

• Managed segmentation, messaging, and brand awareness insights of physicians and consumers during U.S. launch of novel obesity drug. First-year post launch sales totaled over $23M.• Oversaw market research budget of $1M for quantitative and qualitative insights, including direct to consumer print and television advertising and concept testing.• Communicated Go-to-Market strategy to C-level executives during commercial launch.

Danville, Ca, Us

• On contract at Genentech, conducted competitive intelligence for international pharmaceutical brand teams covering products over $1B in ex-US revenue.• Analyzed strategic implications for international brand teams focused on marketed oncology portfolio in gastrointestinal and breast cancers. • Managed Roche Gobal competitive intelligence teams at major international oncology conferences.• Coordinated competitive intelligence cross-functionally for early-stage oncology compounds.

Alameda, California, Us

• Provided commercial insights and competitive assessments to cross-functional clinical project teams, enabling senior management to make strategic investment decisions regarding product development.• Worked cross-functionally to evaluate commercial viability of oncology market opportunities for early stage development assets.• Presented commercial landscape and competitive threat evaluations to executive finance management, providing insights on market opportunities for products in development.• Forecasted revenues for multiple early to mid-stage oncology compounds in clinical development across a variety of liquid and solid tumor indications, enabling senior management to understand commercial potential of products in development.• Managed competitive intelligence efforts at ASCO, ASH and EORTC conferences, identifying threats and opportunities for pipeline assets.• Served as primary interface between Exelixis and research vendors for market intelligence databases

Chicago, Il, Us

• Devised in-line brand strategy for neurological product in European market that led to improvements in sales and marketing efforts.• Conducted disease state opportunity assessment for new product development covering hematological indication, enabling Go/No-Go decision, using primary research and ADIS database resource. Recommended against market entry.• Forecasted financial valuation for single product start-up venture client, and evaluated potential partnership alliances.• Created financial models and performed secondary research on oncology and pain medication portfolios, incorporating market sizing that informed product development strategy. Leveraged IMS and XPonent sources.• Developed payer strategy that drove new product development efforts in metabolic disease marketplace.• Performed conjoint analysis that confirmed commercial feasibility of neurological product and supported in-licensing decision.

Mba, Business Administration And Management, General

Bachelor Of Arts